All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
2,237 recalls · page 16 of 45
-
Class IIofficial
Medical Products Laboratories, Inc. recalls Walgreens Saline Nasal Spray WITH XYLITOLMicrobial contamination of a non-sterile product - microorganism found to be pseudomonas lactis
-
Class IIIofficial
Dr. Reddy's Laboratories, Inc. recalls Varenicline TabletsSub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
-
Class IIIofficial
Teva Pharmaceuticals USA, Inc recalls Carton label: Testosterone Gel 1%Defective Container - A defect in the side-seal which allows leakage of product.
-
Class Iofficial
Fresenius Kabi USA, LLC recalls Famotidine InjectionMicrobial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Sertraline Hydrochloride Tablets USPDefective container - seal not adhering to bottles
-
Class IIofficial
Cipla Limited recalls Phytonadione Injectable EmulsionFailed Stability Specifications: Observed OOS results: eg results for colour index
-
Class IIofficial
Blossom Pharmaceuticals recalls Lanashield Skin BarriercGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls Dynashield Skin ProtectantcGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls Wecare EnemacGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls DynagelcGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls WeCarecGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls Nivagen PharmaceuticalscGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls DynashieldcGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls NivagencGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls NivagencGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls Globe Clotrimazole CreamcGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls Globe Clotrimazole Cream USPcGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin ProtectantcGMP deviations
-
Class IIofficial
Blossom Pharmaceuticals recalls Wecare CalasoothecGMP deviations
-
Class IIofficial
Novocol Pharmaceutical of Canada, Inc. recalls 2% Xylocaine DENTAL with Epinephrine 1:100Defective container: cracked/broken cartridges
-
Class IIofficial
Novocol Pharmaceutical of Canada, Inc. recalls Lidocaine HCI 2% and Epinephrine 1:100Defective container: cracked/broken cartridges
-
Class IIofficial
Novocol Pharmaceutical of Canada, Inc. recalls 3% Polocaine DENTALDefective container: cracked/broken cartridges
-
Class IIofficial
Novocol Pharmaceutical of Canada, Inc. recalls darby dental supplyDefective container: cracked/broken cartridges
-
Class IIofficial
Novocol Pharmaceutical of Canada, Inc. recalls Benco dental Graham CHEMICAL CO.Defective container: cracked/broken cartridges
-
Class IIofficial
Novocol Pharmaceutical of Canada, Inc. recalls Cook-WalteDefective container: cracked/broken cartridges
-
Class IIofficial
Novocol Pharmaceutical of Canada, Inc. recalls OraVerseDefective container: cracked/broken cartridges
-
Class Iofficial
Otsuka ICU Medical LLC recalls POTASSIUM CHLORIDE Inj.Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
-
Class Iofficial
Otsuka ICU Medical LLC recalls POTASSIUM CHLORIDE Inj.Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Agebox recalls Agebox iKids-Growth (Day Formula) capsulesMarketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
-
Class IIofficial
Agebox recalls Agebox iKids-Growth (Night Formula)Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
-
Class IIofficial
Otsuka ICU Medical LLC recalls 0.9% SODIUM CHLORIDE InjectionLack of Assurance of Sterility: Potential for flexible container leaks.
-
Class IIofficial
Cipla USA, Inc. recalls Lanthanum Carbonate chewable tabletsFailed stability specifications: Out of specification for hardness test
-
Class IIofficial
Cipla USA, Inc. recalls Lanthanum Carbonate chewable tabletsFailed stability specifications: Out of specification for hardness test
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Bromocriptine Mesylate CapsulesFailed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls clomiPRAMINE HydrochloridecGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls clomiPRAMINE HydrochloridecGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls clomiPRAMINE HydrochloridecGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.
-
Class IIofficial
Bristol-Myers Squibb Company recalls Opdualag (nivolumab and relatlimab-rmbw) injectionLack of Assurance of Sterility.
-
Class IIofficial
Kenvue Brands LLC recalls TYLENOLDefective Container
-
Class IIIofficial
Imprimis NJOF, LLC recalls Klarity-C Drops (Cyclosporine) 0.1%Subpotent Drug
-
Class IIofficial
Golden State Medical Supply Inc. recalls NIACIN Extended-Release TabletsFailed Dissolution Specifications
-
Class Iofficial
ANTHONY TRINH, 123Herbals LLC recalls SILINTAN 25/pillsMarketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
-
Class IIofficial
Aero Healthcare recalls Acetaminophen 500mg Caffeine 65mg capletsLabeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg.